Home / Drugs / nusinersen

nusinersen

FDA Drug Profile

Drug Details

Generic Name: nusinersen
Brand Names: N/A
Application Number
Sponsor: Ionis Pharmaceuticals Inc.
NDC Codes: 1
Dosage Forms: POWDER
Routes: N/A
Active Ingredients: NUSINERSEN

Indications and Usage

1 INDICATIONS AND USAGE SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. SPINRAZA is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients ( 1 )